Literature DB >> 29569297

Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta-analysis of observational studies.

Digby W Allen1,2,3, Ki Wook Kim1,2, William D Rawlinson1,2,3,4, Maria E Craig1,2,3,5,6.   

Abstract

Virus infections are implicated in the development of type 1 diabetes based on epidemiological, clinical, in vitro cell-based and molecular studies, and animal models. We reviewed the association between virus infections in pregnant women and development of islet autoimmunity or type 1 diabetes in their offspring. We performed a systematic review and meta-analysis, analysed using random effects models, of human studies from Medline and EMBASE without language restriction. Inclusion criteria were as follows: cohort and case-control studies measuring viral nucleic acid in blood, stool, urine, or tissue, or serological tests for viruses, in pregnant women whose offspring developed islet autoimmunity and/or type 1 diabetes. All studies required sufficient data to calculate odds ratios and 95% confidence intervals. The 10 studies (4 case control, 6 nested-case control) that met the eligibility criteria included 2992 participants (953 offspring, 2039 mothers), with varying study design. The 2 outcomes examined were islet autoimmunity (n = 466) and type 1 diabetes (n = 2526). Meta-analysis showed a significant association between virus infection during pregnancy and clinical type 1 diabetes during childhood (odds ratio 2·16, 95% CI 1·22-3·80; P = 0·008; heterogeneity X2  = 1·65, I2  = 40%), but no association with islet autoimmunity (1·45, 0·63-3·31; P = 0·38; X2  = 1·34, I2  = 25%). The increased risk of type 1 diabetes following maternal virus infection is consistent with viraemia involving the fetus during pregnancy and suggests a potential causative link between antenatal infection and type 1 diabetes. Larger prospective birth studies with more frequent sampling, and pathogenesis studies, are required to more clearly establish an aetiological link.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  congenital rubella; coxsackievirus; cytomegalovirus; enterovirus; islet autoimmunity; type 1 diabetes

Mesh:

Year:  2018        PMID: 29569297     DOI: 10.1002/rmv.1974

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  22 in total

1.  Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter].

Authors:  Jessica L Dunne; Sarah J Richardson; Mark A Atkinson; Maria E Craig; Knut Dahl-Jørgensen; Malin Flodström-Tullberg; Heikki Hyöty; Richard E Lloyd; Noel G Morgan; Alberto Pugliese
Journal:  Diabetologia       Date:  2019-04-23       Impact factor: 10.122

Review 2.  Type 1 diabetes-early life origins and changing epidemiology.

Authors:  Jill M Norris; Randi K Johnson; Lars C Stene
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-27       Impact factor: 32.069

Review 3.  Early-life factors contributing to type 1 diabetes.

Authors:  Maria E Craig; Ki Wook Kim; Sonia R Isaacs; Megan A Penno; Emma E Hamilton-Williams; Jennifer J Couper; William D Rawlinson
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

4.  Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study.

Authors:  Lars Krogvold; Angelo Genoni; Anna Puggioni; Daniela Campani; Sarah J Richardson; Christine S Flaxman; Bjørn Edwin; Trond Buanes; Knut Dahl-Jørgensen; Antonio Toniolo
Journal:  Diabetologia       Date:  2022-08-12       Impact factor: 10.460

5.  Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.

Authors:  Olga Kordonouri; David Cuthbertson; Malin Belteky; Bärbel Aschemeier-Fuchs; Neil H White; Elisabeth Cummings; Mikael Knip; Johnny Ludvigsson
Journal:  Diabetologia       Date:  2022-09-09       Impact factor: 10.460

Review 6.  Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?

Authors:  Richard E Lloyd; Manasi Tamhankar; Åke Lernmark
Journal:  Annu Rev Med       Date:  2021-11-18       Impact factor: 16.048

Review 7.  Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes.

Authors:  Jessica L Dunne; Sarah J Richardson; Mark A Atkinson; Maria E Craig; Knut Dahl-Jørgensen; Malin Flodström-Tullberg; Heikki Hyöty; Richard A Insel; Åke Lernmark; Richard E Lloyd; Noel G Morgan; Alberto Pugliese
Journal:  Diabetologia       Date:  2019-01-23       Impact factor: 10.122

8.  Distinct Gut Virome Profile of Pregnant Women With Type 1 Diabetes in the ENDIA Study.

Authors:  Ki Wook Kim; Digby W Allen; Thomas Briese; Jennifer J Couper; Simon C Barry; Peter G Colman; Andrew M Cotterill; Elizabeth A Davis; Lynne C Giles; Leonard C Harrison; Mark Harris; Aveni Haynes; Jessica L Horton; Sonia R Isaacs; Komal Jain; Walter Ian Lipkin; Grant Morahan; Claire Morbey; Ignatius C N Pang; Anthony T Papenfuss; Megan A S Penno; Richard O Sinnott; Georgia Soldatos; Rebecca L Thomson; Peter J Vuillermin; John M Wentworth; Marc R Wilkins; William D Rawlinson; Maria E Craig
Journal:  Open Forum Infect Dis       Date:  2019-01-16       Impact factor: 3.835

Review 9.  Intrauterine programming of obesity and type 2 diabetes.

Authors:  Denise S Fernandez-Twinn; Line Hjort; Boris Novakovic; Susan E Ozanne; Richard Saffery
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 10.  Endocrine Disrupting Chemicals and Type 1 Diabetes.

Authors:  Barbara Predieri; Patrizia Bruzzi; Elena Bigi; Silvia Ciancia; Simona F Madeo; Laura Lucaccioni; Lorenzo Iughetti
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.